Melanoma Study Day

Melanoma Study Day

Friday 20 November 2026

Overview

This multidisciplinary study day brings together expert speakers to explore the evolving management of melanoma from multiple clinical perspectives. As the fastest rising cancer in the UK, melanoma presents growing challenges and opportunities across prevention, diagnosis, treatment and survivorship. With new therapies emerging and pathways continuing to develop, high-quality care depends on coordinated working across specialties and a strong understanding of the latest evidence.

Throughout the day, you will explore the changing melanoma landscape, from public health policy and prevention through to surgical and medical treatment advances, current research activity and patient-centred models of care. The programme is designed to support professionals working across melanoma services to strengthen their knowledge, broaden their perspective and build confidence in delivering joined-up, evidence-based care.

This event offers a valuable opportunity to learn from specialists working across the melanoma pathway, connect with colleagues from different disciplines, and reflect on how evolving practice is improving outcomes for patients.

Key information 

Delivery type  

Hybrid:

  • Face-to-face (in-person teaching sessions at a specific venue)
  • Online (live)

Delivery style

  • Lectures
  • Case discussions
  • Expert updates
  • Multidisciplinary learning

Duration  

One day

Experience level  

All

Cost

  • Onsite: £110
  • Virtual: £110
  • Low- and Middle-Income Countries (LMIC): £50
  • Student: £70
  • Offer 5 for 4 (onsite and virtual): £84
  • Pharma and industry: £200

08:45 Registration

09:00 Welcome & Introduction
Jackie Hodgetts, Advanced Clinical Practitioner, The Christie NHS Foundation Trust

Session 1: Melanoma Pathophysiology
Chair, Jackie Hodgetts, Advanced Clinical Practitioner, The Christie NHS Foundation Trust

09:15 Melanoma Biology And Molecular Pathways
Dr Ann Tivey, Honorary Research Fellow, The Christie NHS Foundation Trust

09:35 An Overview Of Rare Melanoma Subtypes
Speaker TBC

Session 2: Sun Safety & Risks of Sunbeds
Chair, Jackie Hodgetts, Advanced Clinical Practitioner, The Christie NHS Foundation Trust

09:55 UV Radiation And Skin Damage, Incidence And Risk Factors And Prevention Basics
Dr John Newsham, Consultant Dermatologist, Northern Care Alliance

10:15 Patient Story

10:45 Listen to be heard
Helen Bradley, Senior Trainer and Programme Lead, Maguire Communication & Leadership Skills Academy

11:00 Panel Q&A

11:15 Coffee

Session 3: Melanoma Staging, Diagnostic Workup & Surgical Management
Chair, Dr Patricio Serra, Consultant Medical Oncologist, The Christie NHS Foundation Trust

11:30 Histopathology and Genomics
Dr Lynne Jamieson, Consultant Dermatopathologist, Northern Care Alliance

11:50 Surgical Principles And Patient Pathway
Emma Farrow, Surgical Clinical Nurse Specialist, The Christie NHS Foundation Trust
Caroline Owens, Plastic Surgical Clinical Nurse Specialist, The Christie NHS Foundation Trust

12:10 Surgical Advances And Neo-Adjuvant Immunotherapy
Prof Rowan Pritchard Jones, Consultant Plastic Reconstructive Surgeon, Mersey and West Lancashire Teaching Hospital NHS Trust

Panel Q&A MDT Case Study Discussion

12:30 Lunch

12:45 Session 4: Immunotherapy in Melanoma
Chair TBC

13:30 Checkpoint Inhibitors In Melanoma
Speaker TBC

13:50 Acute Management Of Immune-Related Adverse Events
Speaker TBC

14:10 Tumour Infiltrating Lymphocytes
Dr Jon Lim, Consultant Medical Oncologist, The Christie NHS Foundation Trust

14:30 Immunotherapy Late Effects
Prof Ruth Board, Consultant Medical Oncologist, Royal Preston Hospital

14:50 Panel Q&A

15:05 Break

Session 5: Other Treatment Options And Clinical Trials For Melanoma
Chair TBC

15:20 Current Clinical Trials In Melanoma
Dr Rebecca Lee, Consultant Clinical Oncologist, The Christie NHS Foundation Trust

15:40 SRS For Melanoma Brain Metastases
Dr Rovel Colaco, Consultant Clinical Oncologist, The Christie NHS Foundation Trust

16:00 Early Phase Clinical Trials
Dr Rachel Woodford, Consultant, The Christie NHS Foundation Trust

16:20 T-VEC
Mr McKirdy, Plastic Surgery Consultant, Royal Preston Hospital

16:40 Panel Q&A

16:55 Close of Day

Learning outcomes

By the end of this study day, you should be able to:

  • Understand current melanoma epidemiology and staging
  • Recognise the importance of public health policy relating to UV radiation and prevention
  • Explore evolving treatment approaches across surgical and medical oncology
  • Gain insight into current research studies, clinical trials and emerging therapies
  • Strengthen your understanding of multidisciplinary and patient-centred melanoma care

Why choose this programme?

Melanoma care is evolving rapidly, with new treatments, growing research activity and increasing emphasis on prevention and survivorship. This study day offers a timely, multidisciplinary update for professionals involved in melanoma care, helping you stay informed, connected and confident in practice.

Who is it for?

Suitable for:

  • Nurses
  • Allied Health Professionals
  • Specialist nurses
  • Doctors
  • Student nurses
  • Anyone with a special interest in, or involvement in, the care of patients with melanoma

How to book/learn more

You can book this course on Eventbrite.

Not ready to book? Find out more